Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎ New York, NY
(646) 856-9261
info@inspirna.com

Board of Directors

Dieter Weinand

Dieter is Chairman of the Board of Inspirna.

Masoud Tavazoie, M.D., Ph.D.

Masoud is Chief Executive Officer and co-founder of Inspirna.

Eric Rowinsky, M.D.

Eric is the Chief Medical Officer of Hummingbird Bioscience.

Jack Nielsen

Jack B. Nielsen is a Partner of Vivo Capital.

Michael Ginder

Michael is currently a research analyst at Sands Capital, a leading growth-oriented investment firm.

Antoine Papiernik

Antoine Papiernik is a Managing Partner at Sofinnova Partners, which he joined in 1997.

Raymond Camahort, Ph.D.

Ray is a Partner at Novo Ventures.

Peter Van Vlasselaer, Ph.D.

Peter is Executive Chairman of Amphivena as well as Board Chair of Asceneuron.

Jue Pu

Jue leads the cancer biomarker and liquid biopsy research and development at Lepu Medical.